Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company Vir Biotechnology. Joining us today from Vir CFO, Sung Lee; and CMO, Phil Pang.
For those of you joining on the webcast, if you want to ask a question, you can do so at any time. You can submit a question using the chat box feature at the bottom of your screen. So with that we'll get started. Sung and Phil, thanks so much for joining us today.
Yeah. Thanks, Joey, for hosting us.
Questions & Answers
Great. So high level -- Vir recently had some management changes bringing in a new CEO, Marianne Backer and some -- you also recently joined the company. What attracted you to Vir? And secondly, is there any change in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |